EC Number   |
Title |
Organism |
|---|
    1.13.11.34 | 5 S,15 S-Dihydroperoxyeicosatetraenoic Acid (5,15-diHpETE) as a lipoxin intermediate Reactivity and kinetics with human leukocyte 5-lipoxygenase, platelet 12-lipoxygenase, and reticulocyte 15-lipoxygenase-1 |
Homo sapiens |
| 1.13.11.34 | ATP allosterically activates the human 5-lipoxygenase molecular mechanism of arachidonic acid and 5(S)-hydroperoxy-6(E),8(Z),11(Z),14(Z)-eicosatetraenoic acid |
Homo sapiens |
| 1.13.11.34 | Characterization and cellular localization of human 5-lipoxygenase and its protein isoforms 5-LODELTA13, 5-LODELTA4 and 5-LOp12 |
Homo sapiens |
| 1.13.11.34 | Characterization of the interaction of human 5-lipoxygenase with its activating protein FLAP |
Homo sapiens |
| 1.13.11.34 | Characterization of the molecular mechanism of 5-lipoxygenase inhibition by 2-aminothiazoles |
Homo sapiens |
| 1.13.11.34 | Design, synthesis and cellular characterization of a dual inhibitor of 5-lipoxygenase and soluble epoxide hydrolase |
Homo sapiens |
| 1.13.11.34 | Design, synthesis, and structure-activity relationship studies of dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase |
Homo sapiens |
| 1.13.11.34 | Different forms of vitamin E and metabolite 13-carboxychromanols inhibit cyclooxygenase-1 and its catalyzed thromboxane in platelets, and tocotrienols and 13-carboxychromanols are competitive inhibitors of 5-lipoxygenase |
Homo sapiens |
| 1.13.11.34 | Discovery of a novel 2,5-dihydroxycinnamic acid-based 5-lipoxygenase inhibitor that induces apoptosis and may impair autophagic flux in RCC4 renal cancer cells |
Homo sapiens |
| 1.13.11.34 | Evaluation of cyrhetrenyl and ferrocenyl precursors as 5-lipoxygenase inhibitors - biological and computational studies |
Homo sapiens |
